7.8 C
New York
Friday, November 25, 2022

Muscular Dystrophy Association Announces Programming on Access to Employment & Inclusive Workforce Culture During National Disability Employment Awareness Month in October – Yahoo Finance

NEW YORK, Oct. 3, 2022 /PRNewswire/ — The Muscular Dystrophy Association (MDA) announces educational programming, Quest Media platform content, and DEI Coalition engagement, all aimed at disability disruption and amplification of the equity equation, featured throughout National Disability Employment Awareness Month (NDEAM) in October.
MDA’s DEI commitment and goals for inclusion are to: elevate awareness and create an accessible world where every individual can participate in all aspects of community life; promote and deliver opportunities for dialogue that enhances understanding and emphasizes the lived experience of our community; provide education, programming, and resources aimed at overcoming barriers to accessing life’s milestones; and collaborate with other thought-leaders to ensure access and inclusion for all.
“We at the Muscular Dystrophy Association are committed to leveraging our voice and platforms to promote diversity, equity, and inclusion, elevating the conversation around disability is diversity. We work to ensure individuals living with disability have the same access to personal freedoms and independence. At MDA, we believe unity is strength,” said Kristine Welker, Chief of Staff, MDA.
Throughout October, Quest Media the adaptive lifestyle platform of MDA, will feature multiple pieces of content for NDEAM. We feature Michael Lewis, MDA’s Director of Disability Policy, and Tiffany Meehan, Inclusively’s Vice President of Marketing for a Quest blog about knowing your rights under the Americans with Disabilities Act (ADA) during the interview process. MDA’s partner, Inclusively, is a workforce inclusion platform making strides in the disability employment space by matching companies eager to diversify their staff with qualified candidates. “Our employers are working with us because they’re committed to hiring candidates with disabilities,” says Meehan. “They approach the entire hiring process with accommodations in mind.” Mindy Henderson, MDA’s Director and Editor-in-Chief of Quest Media, also interviewed Sarah Bernard, Inclusively’s Co-Founder and Chief Operating Officer, about creating an inclusive work culture for a podcast episode to be released later this month.
“Inclusively recommended that I apply to my current position at MDA. As someone with a neuromuscular disability myself, it is the honor of my lifetime to work at MDA to continue the effort of providing people across the NMD community effective access to healthcare. I do this not only because the work is important, but also because the people here at MDA care about people like me—not just as constituents, but as people. Our hiring practices are just one example of it,” said Joel Cartner, Director of Access Policy, MDA.
Brian Wynne, CEO of Acosta, another MDA partner, will also be featured on the Quest blog about the company’s dedication to creating empowering employment opportunities for people with disabilities. Wynne, a business leader, and the father of a child with a disability, shares Acosta’s priorities of fostering a welcoming and inclusive work environment. “To have a successful business, in any industry, you need the best talent available. And if you want to have the best talent, you have to make sure you’re including everyone in the talent pool — all of the people who have wonderful talents, skills, and abilities, not excluding people with disabilities.”
“We are proud to be a leading organization in contributing to the equity equation,” said Welker. “In recognition of the important role people with disabilities play in a diverse and inclusive American workforce, the MDA DEI Coalition has been tireless in its efforts to help organizations connect with the largest untapped pipeline of talent is this country in partnership with Inclusively. In addition, our leadership team is always on the road, participating in initiatives to remove barriers for our community from engagements at The White House, on Capitol Hill, in educational partnership with the Smithsonian Institution, advancing access to treatments with the US Food and Drug Administration, and with corporate partners such as Financial Force.”
MDA’s DEI Coalition works to ensure individuals living with disability have equal access. MDA believes that employer and employee cultivation is a key component to creating a culture of inclusion, and NDEAM is a time for employers to ensure their policies and training are inclusive, and a time for the disability community to learn about programs and policies in place to help people further their career goals.
“I’m proud to participate on the frontlines of this effort with the Muscular Dystrophy Association’s DEI Coalition, working to ensure people with disabilities fully participate in the national conversation around diversity, equity, and inclusion,” said Dr. Chris Rosa, President and CEO of the Viscardi Center and MDA Board member. The partnership between the Muscular Dystrophy Association and equity-focused organizations like Viscardi Center will help to ensure that people with disabilities have meaningful opportunities to be fully included in the new American workforce.”
Educational Programming:
October 7 on-demand – MDA Access to Employment Workshop
This workshop, sponsored by Genentech provides an overview of:
October 12-13 from 3-6:30pm ET both days – MDA Engage: Technology for Independence Seminar
This seminar sponsored by Mitsubishi Tanabe Pharma America provides information
from leading experts in the neuromuscular disease community on technology that
supports independence in daily living, including:
October 18-19 from 3-6:30pm ET both days – MDA Engage: Myasthenia Gravis Symposia This two-day educational event aims to empower individuals and families with knowledge and resources specific to myasthenia gravis (MG). Information will be provided by experts in the field and offer an opportunity for individuals living with MG to connect and build their network of support.
October 26 – Muscular Dystrophy Association and Smithsonian Science Education Center co-host an online youth discussion to allow educators from the Zero Barriers in STEM education summit the chance to hear from youth involved in the Muscular Dystrophy Association’s youth mentoring program. MDA youth will provide participating educators with insights into their experience accessing STEM in school and ways to better support students with disabilities. General Motors and MDA teamed up at the Smithsonian Science Education Center’s Zero Barriers in STEM education summit this past July to promote inclusion in STEM education and STEM careers. MDA’s STEM Connections program provides hands-on activities for kids and young adults living with neuromuscular disease to learn STEM concepts and explore STEM-based careers in a supportive environment. This year’s program involves two robust components from MDA Summer Camp to fall programming. This program is supported by a grant from General Motors.

Quest Media the adaptive lifestyle platform of the Muscular Dystrophy Association will feature content on knowing your rights in the interview process, a podcast with corporate leaders on creating an inclusive culture at work, and more.

On the Road with MDA: During NDEAM, MDA will launch a new MDA LinkedIn series highlighting MDA’s extended leadership team as they attend and speak at prestigious conferences and meeting with valued partners, such as The White House, Smithsonian Institution, US Food and Drug Administration (FDA), Financial Force and more.
Muscular Dystrophy Association (MDA) is the #1 voluntary health organization in the United States for people living with muscular dystrophy, ALS, and related neuromuscular diseases. For over 70 years, MDA has led the way in accelerating research, advancing care, and advocating for the support of our families. MDA’s mission is to empower the people we serve to live longer, more independent lives. To learn more visit mda.org. Follow on InstagramFacebookTwitterTikTokLinkedIn, and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/muscular-dystrophy-association-announces-programming-on-access-to-employment–inclusive-workforce-culture-during-national-disability-employment-awareness-month-in-october-301639008.html
SOURCE Muscular Dystrophy Association
Apellis and Belite Bio were among the worst-performing biotech stocks Monday after presenting test results in two eye diseases.
Bluebird Bio has received a lot of attention for pricing two FDA-approved gene therapies at around $3 million, but its financial future remains uncertain.
Eli Lilly (NYSE: LLY) was already having a great year in the stock market, but on Sept. 28, the company's shares jumped by about 7%. The move happened after biotech giant Biogen and its partner Esai reported positive top-line results from a phase 3 clinical trial for an Alzheimer's disease (AD) therapy candidate, lecanemab. Eli Lilly is working on its own AD treatment, donanemab, and the market counted Biogen's win as Eli Lilly's too.
Bristol Myers (BMY) expects recent drug approvals to generate an incremental stream of revenues and combat competition for its key drugs.
AbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new indications. They are expected to drive revenues once Humira loses U.S. exclusivity in 2023.
Amylyx Pharmaceuticals' co-founders have said they want to use their newfound platform to bring down barriers to ALS care.
Wilmington biotech company Incyte has agreed to acquire Villaris Therapeutics in a deal valued at up to $1.36 billion. The centerpiece of the deal is auremolimab, a monoclonal antibody that is under development to treat the skin disorder vitiligo — but has potential applications beyond dermatology. Villaris, based in Cary, North Carolina, was founded in 2019 and is backed by Medicxi, a health care-focused investment firm based in London.
Is Pfizer stock a sell on an expected decline for Covid vaccine sales in the third quarter? Is PFE stock now a sell?
By Mark Gilman, Benzinga
On Sept. 19, Novartis (NYSE: NVS) shared positive news with investors regarding the clinical trial results for its biosimilar drug candidate to Amgen's (NASDAQ: AMGN) osteoporosis medicine Prolia. With Prolia set to lose exclusivity in the U.S. in 2025, Novartis could be close to booking some revenue from its biosimilar drug. Let's go over the outcome of the clinical trial and the U.S. osteoporosis market to figure this out.
bluebird's (BLUE) recent FDA approvals for its gene therapies, namely beta-cel for beta-thalassemia and eli-cel for cerebral adrenoleukodystrophy, are expected to drive the top line.
The vegetable was shown to lower blood sugar levels and cholesterol levels
The University of Illinois (UIUC) has partnered with Amazon, Apple, Google, Meta, Microsoft and nonprofits on the Speech Accessibility Project.
For those of us who have trouble sleeping, the past month has brought two new scientific studies to keep us awake at night. First, there was a paper presented at the European Society of Cardiology sharing the news that seven in 10 heart attacks or strokes experienced by those over 50 could be prevented if everyone got “a decent night’s sleep”. The best scores in cardiac health were achieved by those who slept seven or eight hours a night.
Most of Biogen's (BIIB) key drugs are facing declining sales. Despite these challenges, we are hopeful that potential new product launches such as lecanemab, zuranolone and additional biosimilars can help revive growth.
Arizona banned almost all abortions on 24 September under new law
The condition is as common as it is embarrassing—but it’s not something you have to live with indefinitely.
Novo Nordisk (NVO) expects new acquisitions to diversify its portfolio of marketed drugs and help combat the stiff competition in the diabetes market.
Lydia Zuraw/KHNBy Jay HancockI woke up in a strange bedroom with 24 electrodes glued all over my body and a plastic mask attached to a hose covering my face.The lab technician who watched me all night via video feed told me that I had “wicked sleep apnea” and that it was “central sleep apnea”—a type that originates in the brain and fails to tell the muscles to inhale.As a journalist—and one terrified by the diagnosis—I set out to do my own research. After a few weeks of sleuthing and interviewin
Whole-body EMS suits are the new big thing in fitness, but do they work?


Related Articles


Please enter your comment!
Please enter your name here

Latest Articles